# Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

> **NCT07410039** · PHASE4 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Neuromyelitis Optica Spectrum Disorder Attack

## Interventions

- **DRUG:** Eculizumab+IVMP
- **DRUG:** IVIG+IVMP
- **DRUG:** IVMP

## Key facts

- **NCT ID:** NCT07410039
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07410039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07410039, "Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07410039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*